Ö÷²¥ÓÕ»ó
Sign-up for our newsletter
MAIN
Event Calendar
Awardee Reports
ABOUT DIACOMP
Citing Ö÷²¥ÓÕ»ó
Contact
Committees
Institutions
Awardee Reports
Publications
Bioinformatics
RESOURCES
Protocols & Methods
Reagents & Resources
Mouse Diet
Breeding Schemes
Validation Criteria
IMPC / KOMP Data
Publications
Bioinformatics
CONTACT
Ö÷²¥ÓÕ»ó
Login
▹
Publications
Publication
Oxidative stress-dependent MMP-13 activity underlies glucose neurotoxicity.
Authors
Waldron AL, Schroder PA, Bourgon KL, Bolduc JK, Miller JL, Pellegrini AD, Dubois
AL, Blaszkiewicz M, Townsend KL, Rieger S
Submitted By
Sandra Rieger on 1/16/2018
Status
Published
Journal
Journal of diabetes and its complications
Year
2018
Date Published
3/1/2018
Volume : Pages
32 : 249 - 257
PubMed Reference
Abstract
A complication of diabetes is neuropathy, a condition of sensory axon
degeneration that originates in the epidermis. The mechanisms remain unknown but
reactive oxygen species (ROS) have been implicated in this condition. In this
study, we assessed the role of ROS and a candidate downstream target, MMP-13 in
glucose-induced sensory axon degeneration in zebrafish and mice., The effects of
glucose on metabolism and sensory axon degeneration were assessed using qPCR and
live imaging. ROS were analyzed using pentafluorobenzene-sulfonyl fluorescein
and activation of the NF-?B stress response was determined using Tg(NF-?B:GFP)
zebrafish. The role of MMP-13 and ROS in glucose-dependent axon degeneration was
determined in zebrafish following treatment with the antioxidant,
N-acetylcysteine and the MMP-13 inhibitor, DB04760. Neuropathic mice fed on a
high-fat/high-sugar diet were treated with the MMP-13 inhibitor, CL-82198 to
assess sensory recovery., Glucose treatment of zebrafish induced metabolic
changes that resemble diabetes. Sensory axon degeneration was mediated by
ROS-induced MMP-13 and prevented upon antioxidant treatment or MMP-13
inhibition. MMP-13 inhibition also reversed neuropathy in diabetic mice., We
demonstrate that zebrafish are suitable to study glucose-induced neurotoxicity.
Given the effects in zebrafish and mice, MMP-13 inhibition may be beneficial in
the treatment of human diabetic neuropathy.
Investigators with authorship
Name
Institution
Sandra Rieger
University of Miami
Complications
All Complications
Bioinformatics
Bone
Cardiomyopathy
Cardiovascular
Gastro-Intestinal (GI)
Nephropathy
Neuropathy & Neurocognition
Pediatric Endocrinology
Retinopathy
Uropathy
Wound Healing
Welcome to the Ö÷²¥ÓÕ»ó Login / Account Request Page.
Email Address:
Password:
Note: Passwords are case-sensitive.
 Please save my Email Address on this machine.
Not a member?
If you are a funded Ö÷²¥ÓÕ»ó investigator, a member of an investigator's lab,
or an External Scientific Panel member to the consortium, please
request an account.
Forgot your password?
Enter your Email Address and
click here.
ERROR!
There was a problem with the page:
User Info
User Confirm
Please acknowledge all posters, manuscripts or scientific materials that were generated in part or whole using funds from the Diabetic Complications Consortium(Ö÷²¥ÓÕ»ó) using the following text:
Financial support for this work provided by the NIDDK Diabetic Complications Consortium (RRID:SCR_001415, www.diacomp.org), grants DK076169 and DK115255
Citation text and image have been copied to your clipboard. You may now paste them into your document. Thank you!